52 related articles for article (PubMed ID: 33014805)
1. A Novel Nomogram to Predict Survival in Patients With Recurrence of Pancreatic Ductal Adenocarcinoma After Radical Resection.
He C; Sun S; Zhang Y; Lin X; Li S
Front Oncol; 2020; 10():1564. PubMed ID: 33014805
[TBL] [Abstract][Full Text] [Related]
2. Nomogram and competing risk model to predict recurrence after curative surgical resection of PDAC.
Ge JC; Tao M; Li L; Ma ZL; Jiang B; Yuan CH; Wang HY; Peng Y; Xiu DR
Pancreatology; 2021 May; ():. PubMed ID: 34001437
[TBL] [Abstract][Full Text] [Related]
3. Prognostic effect of CD73 in pancreatic ductal adenocarcinoma for disease-free survival after radical surgery.
Qin D; Wei R; Huang K; Wang R; Ding H; Yao Z; Xi P; Li S
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7805-7817. PubMed ID: 37032378
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of diffuse reduction of spleen density on postoperative survival of pancreatic ductal adenocarcinoma: A retrospective study.
Zheng J; He B; Deng L; Zhu X; Li R; Chen K; Zheng C; Wang D; Wang Y; Yu C; Chen G
Asia Pac J Clin Oncol; 2024 Apr; 20(2):275-284. PubMed ID: 36748794
[TBL] [Abstract][Full Text] [Related]
5. The ratio of skeletal muscle mass to body mass index combined with inflammatory immune markers to stratify survival of pancreatic cancer after pancreatoduodenectomy.
Jin J; Xiong G; Peng F; Zhu F; Wang M; Qin R
Eur J Surg Oncol; 2024 Apr; 50(7):108355. PubMed ID: 38703633
[TBL] [Abstract][Full Text] [Related]
6. Multi-institutional development and external validation of machine learning-based models to predict relapse risk of pancreatic ductal adenocarcinoma after radical resection.
Li X; Yang L; Yuan Z; Lou J; Fan Y; Shi A; Huang J; Zhao M; Wu Y
J Transl Med; 2021 Jun; 19(1):281. PubMed ID: 34193166
[TBL] [Abstract][Full Text] [Related]
7. Oligo-like liver metastasis: A novel prognostic indicator to improve survival in pancreatic cancer.
Saito R; Ban D; Mizui T; Takamoto T; Nara S; Esaki M; Shimada K
Ann Gastroenterol Surg; 2024 May; 8(3):481-489. PubMed ID: 38707220
[TBL] [Abstract][Full Text] [Related]
8. Progression of Site-Specific Recurrence of Pancreatic Cancer and Implications for Treatment.
Rompen IF; Levine J; Habib JR; Sereni E; Mughal N; Hewitt DB; Sacks GD; Welling TH; Simeone DM; Kaplan B; Berman RS; Cohen SM; Wolfgang CL; Javed AA
Ann Surg; 2023 Oct; ():. PubMed ID: 37870253
[TBL] [Abstract][Full Text] [Related]
9. Data independent acquisition of plasma biomarkers of response to neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma.
O'Rourke MB; Sahni S; Samra J; Mittal A; Molloy MP
J Proteomics; 2021 Jan; 231():103998. PubMed ID: 33027703
[TBL] [Abstract][Full Text] [Related]
10. Association of Neutrophil, Platelet, and Lymphocyte Ratios with the Prognosis in Unresectable and Metastatic Pancreatic Cancer.
Allen J; Cernik C; Bajwa S; Al-Rajabi R; Saeed A; Baranda J; Williamson S; Sun W; Kasi A
J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33066235
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma.
Wu M; Li X; Liu R; Yuan H; Liu W; Liu Z
J Cancer; 2020; 11(21):6299-6318. PubMed ID: 33033514
[No Abstract] [Full Text] [Related]
12. Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma.
Yadav S; Kasi PM; Bamlet WR; Ho TP; Polley EC; Hu C; Hart SN; Rabe KG; Boddicker NJ; Gnanaolivu RD; Lee KY; Lindstrom TH; Petersen GM; Couch FJ; McWilliams RR
Clin Cancer Res; 2020 Dec; 26(24):6505-6512. PubMed ID: 33028596
[TBL] [Abstract][Full Text] [Related]
13. SYPL1 Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma
Song Y; Sun X; Duan F; He C; Wu J; Huang X; Xing K; Sun S; Wang R; Xie F; Mao Y; Wang J; Li S
Front Oncol; 2020; 10():1482. PubMed ID: 33042794
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of metabolism-related gene signature in prognostic prediction of gastric cancer.
Luo T; Li Y; Nie R; Liang C; Liu Z; Xue Z; Chen G; Jiang K; Liu ZX; Lin H; Li C; Chen Y
Comput Struct Biotechnol J; 2020; 18():3217-3229. PubMed ID: 33209209
[TBL] [Abstract][Full Text] [Related]
15. Multiple Immune Features-Based Signature for Predicting Recurrence and Survival of Inoperable LA-NSCLC Patients.
Guo M; Li W; Li B; Zou B; Wang S; Fan B; Sun X; Wang L
Front Oncol; 2020; 10():571380. PubMed ID: 33154945
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of inflammation-based scores in patients with ampullary carcinoma after pancreaticoduodenectomy.
Sun S; He C; Wang J; Huang X; Wu J; Li S
BMC Cancer; 2020 Oct; 20(1):981. PubMed ID: 33036573
[TBL] [Abstract][Full Text] [Related]
17. Survival Comparison of Neoadjuvant Chemotherapy Followed by Irreversible Electroporation Versus Conversional Resection for Locally Advanced Pancreatic Cancer.
He C; Sun S; Huang X; Zhang Y; Lin X; Li S
Front Oncol; 2020; 10():622318. PubMed ID: 33604301
[TBL] [Abstract][Full Text] [Related]
18. A Nomogram Model to Predict Post-Progression Survival in Esophageal Squamous Cell Carcinoma Patients With Recurrence After Radical Resection.
Leng C; Cui Y; Chen J; Wang K; Yang H; Wen J; Fu J; Liu Q
Front Oncol; 2022; 12():925685. PubMed ID: 35875105
[TBL] [Abstract][Full Text] [Related]
19. Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts.
Zhao C; He C; Lu J; Huang X; Chen C; Lin X
Front Oncol; 2022; 12():832038. PubMed ID: 35463346
[TBL] [Abstract][Full Text] [Related]
20. Breast Cancer Classification Based on Tumor Budding and Stem Cell-Related Signatures Facilitate Prognosis Evaluation.
Xiang Z; He Q; Huang L; Xiong B; Xiang Q
Front Oncol; 2021; 11():818869. PubMed ID: 35083162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
